Health
Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in Patients With Cancer: The CANVAX Cohort Study – DocWire News
J Clin Oncol. 2021 Nov 9:JCO2101891. doi: 10.1200/JCO.21.01891. Online ahead of print.ABSTRACTPURPOSE: The immunogenicity and…
J Clin Oncol. 2021 Nov 9:JCO2101891. doi: 10.1200/JCO.21.01891. Online ahead of print.
ABSTRACT
PURPOSE: The immunogenicity and reactogenicity of SARS-CoV-2 vaccines in patients with cancer are poorly understood.
METHODS: We performed a prospective cohort…
Continue Reading
-
Business16 hours ago10 ASX shares to buy after the market selloff
-
General20 hours ago‘We are here for you’: PM to bring help to flood zones
-
Business15 hours ago$10,000 invested in ANZ shares 5 years ago is now worth…
-
General18 hours agoWe’ve all talked about potential economic consequences for Australia of Trump’s policies. Now they’re happening